Heart of a Champion Custom Case Solution & Analysis

Evidence Brief

1. Financial Metrics

• Contract Value: 80 million over four years, with 45 million remaining in guaranteed salary.
• Insurance Coverage: Policy covers 60 percent of the remaining contract if the player is medically retired, but excludes pre-existing cardiac conditions for new claims.
• Revenue Impact: Projected 18 percent decline in ticket sales and 22 percent drop in local television viewership if the star player is absent for the full season.
• Sponsorship Risk: Three major apparel and beverage sponsors have clauses allowing termination if the team fails to field a competitive roster for two consecutive seasons.

2. Operational Facts

• Medical Diagnosis: Hypertrophic Cardiomyopathy (HCM) identified during a routine physical following a fainting episode.
• Clinical Data: Three independent cardiologists provided conflicting risk assessments; one cited a 1 percent annual risk of sudden cardiac arrest, while two others cited a 3 to 5 percent risk during high-intensity athletic activity.
• Facility Readiness: The home arena is equipped with automated external defibrillators (AEDs) and a dedicated trauma team, but road game facilities vary in emergency response capabilities.
• League Regulations: Section 4.2 of the league bylaws grants the team physician final authority on medical clearance but allows for an independent review panel if contested by the players union.

3. Stakeholder Positions

• Nick Robinson (Athlete): Demands a return to play, citing personal autonomy and a willingness to sign any liability waiver provided by the team.
• Dr. Miller (Team Physician): Refuses to clear the player, citing the Hippocratic Oath and the high probability of a fatal event during peak physical exertion.
• Sarah Jenkins (General Manager): Focused on the competitive window of the team and the financial implications of a 45 million dollar dead-cap hit.
• League Commissioner: Concerned with the precedent of allowing players with known life-threatening conditions to compete, fearing a public relations disaster.

4. Information Gaps

• Absence of long-term longitudinal data on professional athletes competing with HCM under modern beta-blocker treatments.
• Lack of clarity on whether the players union will support a specialized waiver that may weaken collective bargaining protections for other members.
• Uncertainty regarding the specific legal enforceability of a gross negligence waiver in the home state jurisdiction.

Strategic Analysis

1. Core Strategic Question

• The team must decide whether to prioritize the medical duty of care and organizational liability or honor player autonomy and maximize the current competitive window.
• The central dilemma is whether a managed-risk return is ethically and legally defensible given the non-zero probability of a fatal on-court event.

2. Structural Analysis

Applying a Risk-Reward Matrix and Stakeholder Salience lens reveals the following:

• Liability vs. Autonomy: The legal framework heavily penalizes the team for negligence if they ignore medical warnings, yet the player holds significant power via his contract and public influence.
• Financial Exposure: The loss of the player creates a double-hit; the team pays the salary while losing the revenue generated by the player presence.
• Operational Risk: High-intensity sports are the worst possible environment for HCM, making any return a high-consequence gamble regardless of mitigation efforts.

3. Strategic Options

4. Preliminary Recommendation

The team should pursue Medical Retirement. The clinical data suggests a 3 to 5 percent risk, which is unacceptably high for a professional sports setting. The financial loss is significant but manageable compared to the catastrophic legal and reputational damage of an on-court fatality. The team should focus on securing the 60 percent insurance payout and transitioning the player to a coaching or ambassadorial role to maintain brand value.

Implementation Roadmap

1. Critical Path

• Week 1: Form an independent medical board to provide a final, binding assessment to trigger the insurance clause.
• Week 2: Initiate formal negotiations with the players union to ensure the medical retirement is not contested as a breach of contract.
• Week 4: File the insurance claim for the 60 percent salary recovery.
• Week 6: Launch a public relations campaign celebrating the player career and announcing his transition to a front-office role.

2. Key Constraints

• Insurance Verification: The policy requires proof that the player is totally and permanently disabled from professional basketball; any hint of a future return elsewhere voids the claim.
• Collective Bargaining Agreement (CBA): The union may resist a forced retirement, requiring a negotiated settlement that exceeds the insurance payout.

3. Risk-Adjusted Implementation Strategy

To mitigate the risk of the player suing for the right to play, the team must offer a settlement that covers the gap between the insurance payout and the total remaining contract. The plan assumes a 20 percent probability of legal challenge from the athlete, necessitating a contingency fund of 10 million dollars for legal defense or settlement top-offs. The timeline is fixed at 90 days to ensure roster spots can be filled before the next signing window.

Executive Review and BLUF

1. BLUF

The team must deny Nick Robinson medical clearance and initiate the medical retirement process immediately. A 3 to 5 percent annual risk of death is not an actuarial statistic; it is a certainty over a multi-year period. While the 45 million dollar contract hit is painful, the alternative is a fatal event on live television. This would lead to a total collapse of brand equity, multiple negligence lawsuits, and the potential loss of the franchise license. The strategy focuses on capital preservation through insurance and long-term brand protection. Speed is essential to prevent the player from controlling the narrative through social media.

2. Dangerous Assumption

The most dangerous assumption is that a liability waiver signed by the player would hold up in court. In most jurisdictions, a party cannot waive liability for gross negligence. If the team knows the risk is 5 percent and allows play anyway, no document will protect them from a jury award that could exceed 200 million dollars in the event of a death.

3. Unaddressed Risks

• Precedent Risk: Allowing a return with a heart condition sets a standard where every future player can demand to play through life-threatening injuries, citing the Robinson Case as a benchmark.
• Sponsor Contagion: While the focus is on the player, a death on court would likely cause all major sponsors to exit the league entirely to avoid association with a lethal product.

4. Unconsidered Alternative

The analysis did not fully explore a Sign-and-Trade to a market with more lenient medical standards or different state laws regarding athlete autonomy. While ethically questionable, it would transfer the financial and legal risk to another organization while potentially recouping draft assets. This was likely omitted due to the extreme difficulty of finding a willing trade partner under these medical conditions.

5. Final Verdict

APPROVED FOR LEADERSHIP REVIEW